UroGen Pharma Chief Medical Officer Mark Schoenberg exercised Options for 1,667 shares on Sep 7 and sold 871 shares at $42.92 per share on Sep 8. The transactions left him with 59,882 shares and zero derivative securities, giving investors updated visibility into his reported holdings.

Key Highlights

  • The option exercise represented about 100.0% of Mark Schoenberg’s prior derivative securities holding.
  • The exercise left Schoenberg Mark with 0 derivative securities.
  • The option exercise represented about 2.7% of his resulting share holding, while the sale represented about 1.4% of his prior share holding.

UroGen Pharma Ltd. (NASDAQ: URGN) Chief Medical Officer Mark Schoenberg exercised options for 1,667 shares on Sep 7, leaving him with 60,753 shares. The next day, he sold 871 shares at $42.92 per share, after which his reported holding stood at 59,882 shares.

Option Exercise and Share Sale Details

After that transaction, Schoenberg Mark reported 0 derivative securities. The resulting share balance was 59,882. The exercise and sale occurred on consecutive dates, with the records reporting shares and derivative securities separately.

Holding Bases Behind the Reported Percentages

The percentages apply to different holding bases. The option exercise equaled about 2.7% of the resulting share holding, while the sale equaled about 1.4% of the prior share holding. The exercise represented about 100.0% of the prior derivative securities holding.